Catalyst Wire Dossier Catalyst Wire Dossier

Brimonidine tartrate 0.33% Gel (Mirvaso)

brimonidine tartrate · Galderma
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Brimonidine tartrate 0.33% Gel (Mirvaso), covering 2015-09-30 to 2015-09-30. Get the full timeline:

Most recent: Clinical Trial Update: Finacea 15% and Brimonidine 0.33% Gel in the Treatment of Rosacea - A Pilot Study [Phase 4]

See pricing